Key facts
- It has raised $14.5M; the latest was Early Stage VC ($14.5M) in Apr 2026.
- Notable investors include Suzhou Guofa Venture Capital, Qianhai FoF, Changjiang Growth Capital Investment Company, Sherpa Healthcare Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Chengfeng Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Chengfeng Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chengfeng Technology
Manufacturer of cannulas for extracorporeal life support intended to assist critical cardiac and respiratory care. The company offers precision-engineered cannulas developed by experienced cardiac surgeons and medical device specialists, enabling hospitals and surgical teams to deliver advanced extracorporeal life support with improved safety and reliability.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Chengfeng Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chengfeng Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chengfeng Technology in its N-PORT filings yet. We sweep new filings monthly.